Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses
Research and development	$ 14,981	$ 9,183	$ 42,364	$ 23,655
General and administrative	4,842	3,874	14,288	9,464
Total operating expenses	19,823	13,057	56,652	33,119
Loss from operations	(19,823)	(13,057)	(56,652)	(33,119)
Interest and other income (expense), net	812	116	1,286	(473)
Net loss	(19,011)	(12,941)	(55,366)	(33,592)
Unrealized gain (loss) on marketable securities	(79)	(5)	(1,144)	42
Total comprehensive loss	(19,090)	(12,946)	(56,510)	(33,550)
Net loss	$ (19,011)	$ (12,941)	$ (55,366)	$ (33,592)
Net loss per common share, basic	$ (0.46)	$ (0.32)	$ (1.35)	$ (1.33)
Net loss per common share, diluted	$ (0.46)	$ (0.32)	$ (1.35)	$ (1.33)
Weighted average number of common shares outstanding used in computation of net loss per common share, basic	41,375,537	40,669,412	41,149,393	25,190,479
Weighted average number of common shares outstanding used in computation of net loss per common share, diluted	41,375,537	40,669,412	41,149,393	25,190,479